• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞转录组学揭示甲状腺癌中的间变转化。

Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics.

机构信息

Department of Biochemistry and Molecular Genetics, and.

Center for Cancer Genomics, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.

出版信息

J Clin Invest. 2023 Jun 1;133(11):e169653. doi: 10.1172/JCI169653.

DOI:10.1172/JCI169653
PMID:37053016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10231997/
Abstract

The deadliest anaplastic thyroid cancer (ATC) often transforms from indolent differentiated thyroid cancer (DTC); however, the complex intratumor transformation process is poorly understood. We investigated an anaplastic transformation model by dissecting both cell lineage and cell fate transitions using single-cell transcriptomic and genetic alteration data from patients with different subtypes of thyroid cancer. The resulting spectrum of ATC transformation included stress-responsive DTC cells, inflammatory ATC cells (iATCs), and mitotic-defective ATC cells and extended all the way to mesenchymal ATC cells (mATCs). Furthermore, our analysis identified 2 important milestones: (a) a diploid stage, in which iATC cells were diploids with inflammatory phenotypes and (b) an aneuploid stage, in which mATCs gained aneuploid genomes and mesenchymal phenotypes, producing excessive amounts of collagen and collagen-interacting receptors. In parallel, cancer-associated fibroblasts showed strong interactions among mesenchymal cell types, macrophages shifted from M1 to M2 states, and T cells reprogrammed from cytotoxic to exhausted states, highlighting new therapeutic opportunities for the treatment of ATC.

摘要

最致命的间变性甲状腺癌(ATC)通常由惰性分化型甲状腺癌(DTC)转化而来;然而,肿瘤内复杂的转化过程仍知之甚少。我们通过使用来自不同甲状腺癌亚型患者的单细胞转录组学和遗传改变数据,对间变性转化模型进行了剖析,包括细胞谱系和细胞命运转变。由此产生的 ATC 转化谱包括应激反应性 DTC 细胞、炎症性 ATC 细胞(iATC)、有丝分裂缺陷性 ATC 细胞,并一直延伸到间充质 ATC 细胞(mATC)。此外,我们的分析确定了 2 个重要的里程碑:(a)二倍体阶段,其中 iATC 细胞是具有炎症表型的二倍体细胞;(b)非整倍体阶段,其中 mATC 获得非整倍体基因组和间充质表型,产生大量胶原和胶原相互作用受体。与此同时,癌相关成纤维细胞表现出间充质细胞类型之间的强烈相互作用,巨噬细胞从 M1 状态转变为 M2 状态,T 细胞从细胞毒性状态转变为耗竭状态,这为 ATC 的治疗提供了新的治疗机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/0d167af50b6a/jci-133-169653-g092.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/66ca2d1f7bbe/jci-133-169653-g090.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/5761ae7eba95/jci-133-169653-g093.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/06dfd784fe9f/jci-133-169653-g094.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/2c5c6b37fed9/jci-133-169653-g095.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/9e3403031593/jci-133-169653-g096.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/bdd61a852dcf/jci-133-169653-g097.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/27a743bb1cda/jci-133-169653-g098.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/7046569e5730/jci-133-169653-g099.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/15ae76c691f6/jci-133-169653-g100.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/5d4b147f5b2c/jci-133-169653-g091.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/0d167af50b6a/jci-133-169653-g092.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/66ca2d1f7bbe/jci-133-169653-g090.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/5761ae7eba95/jci-133-169653-g093.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/06dfd784fe9f/jci-133-169653-g094.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/2c5c6b37fed9/jci-133-169653-g095.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/9e3403031593/jci-133-169653-g096.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/bdd61a852dcf/jci-133-169653-g097.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/27a743bb1cda/jci-133-169653-g098.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/7046569e5730/jci-133-169653-g099.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/15ae76c691f6/jci-133-169653-g100.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/5d4b147f5b2c/jci-133-169653-g091.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf8/10231997/0d167af50b6a/jci-133-169653-g092.jpg

相似文献

1
Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics.单细胞转录组学揭示甲状腺癌中的间变转化。
J Clin Invest. 2023 Jun 1;133(11):e169653. doi: 10.1172/JCI169653.
2
Macrophage-Induced Carboxypeptidase A4 Promotes the Progression of Anaplastic Thyroid Cancer.巨噬细胞诱导型羧肽酶 A4 促进间变性甲状腺癌的进展。
Thyroid. 2024 Sep;34(9):1150-1162. doi: 10.1089/thy.2023.0427. Epub 2024 May 13.
3
[NIP7 upregulates the expression of ubiquitin-conjugating enzyme E2 C to promote tumor growth in anaplastic thyroid cancer].[NIP7上调泛素结合酶E2 C的表达以促进间变性甲状腺癌的肿瘤生长]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 May 25;54(3):372-381. doi: 10.3724/zdxbyxb-2024-0708.
4
High Prevalence of 5'UTR Mutations in Anaplastic Thyroid Cancer.间变性甲状腺癌中5'非翻译区突变的高发生率
Thyroid. 2025 Jan;35(1):115-119. doi: 10.1089/thy.2024.0345. Epub 2024 Dec 16.
5
Inhibition of MEK Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.MEK 信号抑制可减弱间变性甲状腺癌的癌症干细胞活性。
Thyroid. 2024 Apr;34(4):484-495. doi: 10.1089/thy.2023.0521. Epub 2024 Jan 16.
6
Involvement of KEAP1/NRF2 pathway in non-BRAF mutated squamous cell carcinoma of the thyroid.KEAP1/NRF2通路在非BRAF突变型甲状腺鳞状细胞癌中的作用
J Pathol. 2025 Aug;266(4-5):481-494. doi: 10.1002/path.6444. Epub 2025 Jul 2.
7
Effects of nutraceuticals on anaplastic thyroid cancer cells.营养保健品对间变性甲状腺癌细胞的影响。
J Cancer Res Clin Oncol. 2018 Feb;144(2):285-294. doi: 10.1007/s00432-017-2555-7. Epub 2017 Dec 2.
8
[F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following -Targeted Therapy.[F]-氟代脱氧葡萄糖摄取作为靶向治疗后残余间变性和低分化甲状腺癌的标志物
AJNR Am J Neuroradiol. 2025 Jun 3;46(6):1260-1267. doi: 10.3174/ajnr.A8588.
9
A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic -Mutated Thyroid Cancer in Japan.在日本转移性突变型甲状腺癌患者中联合使用恩考芬尼和比尼替尼的 2 期研究。
Thyroid. 2024 Apr;34(4):467-476. doi: 10.1089/thy.2023.0547. Epub 2024 Mar 14.
10
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial.双重免疫检查点抑制在侵袭性甲状腺癌患者中的应用:一项2期非随机临床试验。
JAMA Oncol. 2024 Dec 1;10(12):1663-1671. doi: 10.1001/jamaoncol.2024.4019.

引用本文的文献

1
Personalised immunotherapy strategies informed by single cell profiling in thyroid cancer: a mini review.基于甲状腺癌单细胞分析的个性化免疫治疗策略:一篇综述
Front Immunol. 2025 Sep 1;16:1651088. doi: 10.3389/fimmu.2025.1651088. eCollection 2025.
2
Comprehensive analysis of the papillary thyroid carcinoma identifies CSGALNACT1 as a proliferation driver and prognostic biomarker.对甲状腺乳头状癌的综合分析确定CSGALNACT1为增殖驱动因子和预后生物标志物。
Front Cell Dev Biol. 2025 Aug 29;13:1638348. doi: 10.3389/fcell.2025.1638348. eCollection 2025.
3
Single-cell perspective on the Monocyte-to-HDL cholesterol ratio as a metastasis biomarker in papillary thyroid cancer.

本文引用的文献

1
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study.达拉非尼联合曲美替尼治疗 BRAF V600E 突变型甲状腺未分化癌患者:来自 II 期 ROAR 篮子研究的更新分析。
Ann Oncol. 2022 Apr;33(4):406-415. doi: 10.1016/j.annonc.2021.12.014. Epub 2022 Jan 10.
2
Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma.单细胞转录组分析甲状腺癌起始和进展中肿瘤生态系统。
Nat Commun. 2021 Oct 18;12(1):6058. doi: 10.1038/s41467-021-26343-3.
3
Characterizing dedifferentiation of thyroid cancer by integrated analysis.
单细胞视角下单核细胞与高密度脂蛋白胆固醇比值作为甲状腺乳头状癌转移生物标志物的研究
BMC Cancer. 2025 Jul 23;25(1):1203. doi: 10.1186/s12885-025-14373-9.
4
Theaflavin inhibits the malignant phenotype of human anaplastic thyroid cancer 8305C cells by regulating lipid metabolism via PI3K/AKT signaling.茶黄素通过PI3K/AKT信号通路调节脂质代谢,从而抑制人未分化甲状腺癌8305C细胞的恶性表型。
Transl Cancer Res. 2025 Jun 30;14(6):3758-3771. doi: 10.21037/tcr-2025-920. Epub 2025 Jun 27.
5
Spatial Transcriptomics in Thyroid Cancer: Applications, Limitations, and Future Perspectives.甲状腺癌中的空间转录组学:应用、局限性及未来展望
Cells. 2025 Jun 19;14(12):936. doi: 10.3390/cells14120936.
6
NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Development of 3D organoid models to study aggressive thyroid cancers.晚期甲状腺癌的新见解:从机制到治疗:用于研究侵袭性甲状腺癌的3D类器官模型的开发
Eur Thyroid J. 2025 Jul 2;14(4). doi: 10.1530/ETJ-24-0392. Print 2025 Aug 1.
7
Identification of novel prognostic biomarkers for thyroid cancer by integrated transcriptome analysis of metastasis-associated genes.通过转移相关基因的综合转录组分析鉴定甲状腺癌新的预后生物标志物
Front Oncol. 2025 May 19;15:1536270. doi: 10.3389/fonc.2025.1536270. eCollection 2025.
8
NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.晚期甲状腺癌的新见解:从机制到治疗:间变性甲状腺癌起源、生物学特性及治疗的分子见解
Eur Thyroid J. 2025 Jun 2;14(3). doi: 10.1530/ETJ-25-0057. Print 2025 Jun 1.
9
Mutational Landmarks in Anaplastic Thyroid Cancer: A Perspective of a New Treatment Strategy.间变性甲状腺癌的突变标志物:一种新治疗策略的视角
J Clin Med. 2025 Apr 23;14(9):2898. doi: 10.3390/jcm14092898.
10
Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy.间变性甲状腺癌:基因作用、靶向治疗及免疫治疗
Genes Dis. 2024 Aug 30;12(4):101403. doi: 10.1016/j.gendis.2024.101403. eCollection 2025 Jul.
通过综合分析表征甲状腺癌的去分化
Sci Adv. 2021 Jul 28;7(31). doi: 10.1126/sciadv.abf3657. Print 2021 Jul.
4
Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.新型间变性甲状腺癌 PDX 模型和细胞系:扩大遗传多样性的临床前模型。
J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4652-e4665. doi: 10.1210/clinem/dgab453.
5
Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes.从单细胞转录组中描绘人类肿瘤的拷贝数和克隆亚结构。
Nat Biotechnol. 2021 May;39(5):599-608. doi: 10.1038/s41587-020-00795-2. Epub 2021 Jan 18.
6
SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data.SoupX 去除了基于液滴的单细胞 RNA 测序数据中的环境 RNA 污染。
Gigascience. 2020 Dec 26;9(12). doi: 10.1093/gigascience/giaa151.
7
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.人类食管鳞状细胞癌微环境中的免疫抑制景观。
Nat Commun. 2020 Dec 8;11(1):6268. doi: 10.1038/s41467-020-20019-0.
8
Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma.单细胞 RNA 测序强调了炎症性癌相关成纤维细胞在膀胱尿路上皮癌中的作用。
Nat Commun. 2020 Oct 8;11(1):5077. doi: 10.1038/s41467-020-18916-5.
9
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.2000-2019 年间间变性甲状腺癌患者总生存评估。
JAMA Oncol. 2020 Sep 1;6(9):1397-1404. doi: 10.1001/jamaoncol.2020.3362.
10
Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer.谱系依赖性基因表达程序影响结直肠癌的免疫景观。
Nat Genet. 2020 Jun;52(6):594-603. doi: 10.1038/s41588-020-0636-z. Epub 2020 May 25.